Orthopedic soft tissue repair devices market to grow by USD 5633.11 million from 2022-27

Technavio categorizes the global orthopedic soft tissue repair devices market size as estimated to increase by USD 5,633.11 million between 2022 and 2027. The market’s growth momentum will be progressing at a CAGR of 11.05% during the forecast period. The growth of the market is driven by the rising geriatric population across the globe. In general, older adults heal more slowly than younger ones. Older people typically have low overall strength, flexibility, and balance compared to younger people. As a result, it is more challenging to make up for injury limitations and to resume daily activities. According to the Population Reference Bureau, by 2060, there will be 95 million Americans who are 65 years or older, up from an estimated 52 million in 2018. It is anticipated that the proportion of people 65 years and older will increase from 16% to 23%. As a result, there is a growing demand for both acute and long-term healthcare services, which is anticipated to drive the growth of the global orthopedic soft tissue repair devices market during the forecast period.

Global orthopedic soft tissue repair devices market – Segmentation assessment
Segment overview
Technavio has segmented the market based on product type (fixation devices, tissue scaffold, and cell therapy-based), and end-user (hospitals and clinics, ambulatory surgical centers, and physician’s offices).

• The market growth in the fixation devices segment will be significant during the forecast period. A fixation device is made of artificial material and its purpose is to replace the bone structure. This helps fix and support the bone as it heals from surgery or injury. Immobilization devices can be used for a variety of conditions, including fractures and sports injuries. Musculoskeletal injuries are the primary application for this type of fixation device. Some of the fixation devices are suture anchors and interference screws. Such factors will increase the growth of the segment over the forecast period.

Geography overview
By geography, the global orthopedic soft tissue repair devices market is segmented into North America, Europe, Asia, and Rest of World (ROW). The report provides actionable insights and estimates the contribution of all regions to the growth of the global orthopedic soft tissue repair devices market.

• North America is estimated to contribute 45% to the growth of the global market during the forecast period. North America will bring a significant revenue share to the market in 2022. This is due to increased cases of trauma and knee arthroscopies in the region, as well as an increased number of amputations and sports injuries. Rising healthcare spending and investments in the infrastructure of the sector are also contributing significantly to the expansion of the region, as the cost of expensive orthopedic soft tissue repair surgeries can be reduced. Such factors are expected to boost the demand for orthopedic-related treatments, thus propelling the growth of the North American orthopedic soft tissue repair devices market during the forecast period.

Global orthopedic soft tissue repair devices market – Vendor Analysis
Vendor Landscape – The global orthopedic soft tissue repair devices market is fragmented, with the presence of several global as well as regional vendors. A few prominent vendors that offer orthopedic soft tissue repair devices in the market are Arthrex Inc., Becton Dickinson and Co., Boston Scientific Corp., Conmed Corp., Integra Lifesciences Holdings Corp., Johnson and Johnson, JRF Ortho, LifeCell International Pvt. Ltd., LifeNet Health Inc., Medtronic Plc, MTF Biologics, RTI Surgical Inc., Smith and Nephew plc, Stryker Corp., Tissue Regenix Group Plc, Wright Medical Group NV, Zimmer Biomet Holdings Inc., Acera Surgical Inc., AlloSource, and Amplitude Surgical and others.

A few prominent vendors that offer global orthopedic soft tissue repair devices in the market include:

• Boston Scientific Corp.: The company offers orthopedic soft tissue repair devices such as ACLip.
• Conmed Corp.: The company offers orthopedic soft tissue repair devices such as FiberTak button, Knotless FiberTak soft anchor, and Corkscrew suture anchors.
• Integra Lifesciences Holdings Corp.: The company offers orthopedic soft tissue repair devices such as XenMatrix AB Surgical Graft.
• Johnson and Johnson: The company offers orthopedic soft tissue repair devices such as Fixate suturing devices, tissue bands, and Clik anchors.

Technavio